CoChat

An Open Trial of Paroxetine in Patients With Noncombat-Related, Chronic Posttraumatic Stress Disorder

Marshall, Randall D., Schneier, Franklin R., Fallon, Brian A., Knight, Charles B. G., Abbate, Linda A., Goetz, Deborah, Campeas, Raphael, Liebowitz, Michael R. · 1998 · Journal of Clinical Psychopharmacology
Cited by 154

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

The symptom overlap between posttraumatic stress disorder (PTSD) and other pharmacotherapy-responsive disorders suggests that pharmacotherapy might be effective. Nevertheless, of the eight published placebo-controlled trials investigating the pharmacotherapy of PTSD, only four found statistically significant efficacy for the treatment being studied. This literature possesses a number of methodologic limitations, including the fact that most studies have been conducted with war veterans, who may constitute a more treatment-refractory population. Several open trials and one controlled trial with selective serotonin reuptake inhibitors have reported improvement in some or all core PTSD symptoms (reexperiencing, avoidance, numbing, and hyperarousal). The authors hypothesized that paroxetine might be effective in PTSD, based on findings of its particular efficacy for anxiety and agitation in studies of depressed patients. The study presented here summarizes a 12-week, open-label trial of paroxetine among patients with noncombat-related, chronic PTSD. Outcome was assessed by an independent evaluator, the treating physician, and the patient, with the use of established rating scales for depression, anxiety, general symptoms, and PTSD core symptoms. A repeated-measures analysis of variance revealed highly significant improvement in all three symptom clusters, as well as in associated anxiety, depressive, and dissociative symptoms, with 11 of 17 (65%) patients rated as much or very much improved. The mean reduction in PTSD symptom scores was 48%. Exploratory analyses revealed that cumulative childhood trauma was negatively correlated with pharmacotherapy response (r = -0.52, p = 0.03). There was also significant variation in the time course of response across symptom clusters, which is suggestive of multiple mechanisms of response. Because paroxetine seems a highly promising treatment for all three symptom clusters of PTSD, a placebo-controlled clinical trial is warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00004714-199802000-00003

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 154

Metadata

Authors
Marshall, R. D., Schneier, F. R., Fallon, B. A., Knight, C. B. G., Abbate, L. A., Goetz, D., Campeas, R., & Liebowitz, M. R.
Venue
Journal of Clinical Psychopharmacology
Published
1998-02
Volume
18
Issue
1
Pages
10-18
ISSN
0271-0749 (ISSN-L)
OpenAlex
W2060411854
Cited by
154
References
5
FWCI
20.31
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: An Open Trial of Paroxetine in Patients With Noncombat-Related, Chronic Posttraumatic Stress Disorder. https://app.cochat.ai/papers/10.1097/00004714-199802000-00003
The paper
Marshall, R. D., Schneier, F. R., Fallon, B. A., Knight, C. B. G., Abbate, L. A., Goetz, D., Campeas, R., & Liebowitz, M. R. (1998). An Open Trial of Paroxetine in Patients With Noncombat-Related, Chronic Posttraumatic Stress Disorder. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199802000-00003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.